European viper envenomings: Assessment of Viperfav™ and other symptomatic treatments.
about
Vipera ammodytes bites treated with antivenom ViperaTAb: a case series with pharmacokinetic evaluation.Current treatment for venom-induced consumption coagulopathy resulting from snakebiteThe effect of a single dose of prednisolone in dogs envenomated by Vipera berus--a randomized, double-blind, placebo-controlled clinical trialBilateral Pulmonary Embolism Following a Viper Envenomation in France: A Case Report and ReviewSnakebite management in Iran: Devising a protocolAntivenom for European Vipera species envenoming.Two decades of pharmacovigilance and clinical experience with highly purified rabies immunoglobulin F(ab')2 fragments.Poor efficacy of preemptive amoxicillin clavulanate for preventing secondary infection from Bothrops snakebites in the Brazilian Amazon: A randomized controlled clinical trialHyperglycemia is a risk factor for high-grade envenomations after European viper bites (Vipera spp.) in children.A Single Dose of Viperfav(TM) May Be Inadequate for Vipera ammodytes Snake Bite: A Case Report and Pharmacokinetic EvaluationImmunological cross-reactivity and neutralisation of European viper venoms with the monospecific Vipera berus antivenom ViperaTAbNeurotoxicity of European viperids in Italy: Pavia Poison Control Centre case series 2001-2011.Exotic snake bites in the Czech Republic--Epidemiological and clinical aspects during 15-year period (1999-2013).
P2860
Q33438472-F6BF9ED9-008B-456A-8E6B-4AFF595B116EQ34394906-F8A5D474-3B30-44CD-8CDD-D4055D2C3C10Q35147776-3B251B72-127C-4C4D-ADC0-CCC078A2092AQ36993279-8EE2DB5D-5A79-4C1E-8E18-9612E6356250Q37723218-75783489-FF19-42EF-89DD-0188BC0B3458Q38871647-4B862C82-FA86-4E0A-BFC3-448EF9487598Q38997495-A9176FA4-5695-4514-B6B5-358011D0FAE8Q39418425-144C1441-D9D5-41A3-82BC-7122885971F6Q40306327-CE4FEADB-003D-414A-879D-FE500F790FB8Q42331803-27977E17-FBE6-4F08-8F43-224BCF548B2EQ42847712-BF478901-4465-4628-A436-366447D101C1Q44437909-3489AAAD-AF41-468D-AADD-8307E8C0C8C3Q45352614-B3E3DDBE-E86D-4C0E-A193-6D400A566733
P2860
European viper envenomings: Assessment of Viperfav™ and other symptomatic treatments.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
European viper envenomings: Assessment of Viperfav™ and other symptomatic treatments.
@en
European viper envenomings: Assessment of Viperfav™ and other symptomatic treatments.
@nl
type
label
European viper envenomings: Assessment of Viperfav™ and other symptomatic treatments.
@en
European viper envenomings: Assessment of Viperfav™ and other symptomatic treatments.
@nl
prefLabel
European viper envenomings: Assessment of Viperfav™ and other symptomatic treatments.
@en
European viper envenomings: Assessment of Viperfav™ and other symptomatic treatments.
@nl
P2093
P2860
P1433
P1476
European viper envenomings: Assessment of Viperfav™ and other symptomatic treatments.
@en
P2093
David Boels
Jean Francois Hamel
Marie Bretaudeau Deguigne
Patrick Harry
P2860
P304
P356
10.3109/15563650.2012.660695
P407
P577
2012-03-01T00:00:00Z